Disease Model Induced Pluripotent Stem Cells
Create Ideal Screening Cell Lines for Accelerated Drug Discoveries
Disease model iPS Cell lines
- Reprogrammed using standard OSKM factors
- Certified pluripotent with positive immunostaining
- Study the disease process more accurately with better models
Disease and Patient-specific iPS Cell Lines
SBI and DV Biologics have partnered to develop novel Human iPS cell lines from patient-derived sources. Utilizing iPS cell lines from these disorders represents an opportunity to recapitulate both normal and pathological tissue formation in vitro for the ideal drug development screening cell line to facilitate new therapeutic discovery and disease modeling.
Available Disease iPS Cell Lines
• Type I Diabetes: Autoimmune Model
• MLD: Polyneuropathy Model
• Muscular Dystrophy: Muscle development Model
• Glioblastoma: Tumorigenic Model
• ALS: Neurodegeneration Model
• Type II Diabetes: Metabolic Model
• Parkinson's Disease: Neurodegenerative disorder Model